BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2020 3:38:05 PM | Browse: 874 | Download: 1688
 |
Received |
|
2020-05-15 16:09 |
|
Peer-Review Started |
|
2020-05-15 16:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-05-21 20:56 |
|
Revised |
|
2020-05-24 05:18 |
|
Second Decision |
|
2020-09-21 10:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-22 05:41 |
|
Articles in Press |
|
2020-09-22 05:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-10-18 08:55 |
|
Publish the Manuscript Online |
|
2020-10-21 15:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro and Ricardo U Macías-Rodríguez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ricardo U Macías-Rodríguez, MD, MSc, PhD, Assistant Professor, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Mexico City 14080, Mexico. ricardomacro@yahoo.com.mx |
| Key Words |
Non-alcoholic fatty liver disease; Liver fibrosis; Clinical assessment; Diagnosis; Treatment; Test accuracy |
| Core Tip |
The most important liver-related factor associated with adverse clinical outcomes and mortality in patients with non-alcoholic fatty liver disease (NAFLD) is the presence and progression of fibrosis; its progression depends upon genetic, clinical, and biochemical risk factors, that must be assessed in order to identify patients at risk. To be able to accurately identify fibrosis we must take into account the diagnostic ability of each method and its possible variations according to the local prevalence and the selected cutoffs. This review summarizes the available data on assessment and management of NAFLD with a comprehensive analysis of the current diagnostic methods. |
| Publish Date |
2020-10-21 15:38 |
| Citation |
Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(39): 5919-5943 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i39/5919.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i39.5919 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
